734 filings
Page 10 of 37
DEFA14A
dlp1zfos x4l0
11 Sep 17
Additional proxy soliciting materials
12:00am
UPLOAD
y8q9 du9co
6 Sep 17
Letter from SEC
12:00am
8-K
fedlsgbbm5b1 jbcsb
5 Sep 17
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible
12:00am
PREC14A
sg1x2y
29 Aug 17
Preliminary proxy with contested solicitation
12:00am
DFAN14A
ykbyuk9sg9 ua48
14 Aug 17
Additional proxy materials by non-management
12:00am
8-K
9qzyx
11 Aug 17
Peregrine Announces Measures to Reduce Costs, Facilitate Profitability and Strengthen its Operations
12:00am
DEFA14A
l89bgz jp
11 Aug 17
Additional proxy soliciting materials
12:00am
DEFA14A
9lame0a9nbr0wl37k
31 Jul 17
Additional proxy soliciting materials
12:00am
8-K
9iw ld4qkp9ktx
25 Jul 17
Other Events
12:00am
DEFA14A
ikr8kpj
21 Jul 17
Additional proxy soliciting materials
12:00am
DFAN14A
4uw8t8w4ptl4pz
20 Jul 17
Additional proxy materials by non-management
12:00am
8-K
eibln9cgnm5a p5
14 Jul 17
Results of Operations and Financial Condition
12:00am
DEFA14A
j2rri45t44p4qajje
14 Jul 17
Additional proxy soliciting materials
12:00am
DFAN14A
9vowb
13 Jul 17
Additional proxy materials by non-management
12:00am
8-K
q6rautlzl7ruvei
7 Jul 17
Peregrine Pharmaceuticals Announces Reverse Stock Split
12:00am
8-K
w5b9ls 0y
7 Jun 17
Other Events
12:00am
8-K
d0210lhop8w
6 Jun 17
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible
12:00am